NCT00257959View on ClinicalTrials.gov

Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

PHASE4CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

October 31, 2004

Conditions

Ventricular Tachycardia

Interventions

DRUG

amiodarone beta blocker sotalol

Trial Locations (1)

Unknown

McMaster University, Hamilton

Sponsors

Collaborators (1)

Abbott Medical Devices

All Listed Sponsors

collaborator

Abbott Medical Devices

INDUSTRY

lead

Connolly, Stuart, M.D.

INDIV

NCT00257959 - Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) | Biotech Hunter | Biotech Hunter